These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30708099)

  • 1. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.
    Chen C; Lin J; Li L; Zhu T; Gao L; Wu W; Liu Q; Ou S
    Life Sci; 2019 Mar; 220():106-116. PubMed ID: 30708099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
    Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element.
    Tamaki M; Tominaga T; Fujita Y; Koezuka Y; Ichien G; Murakami T; Kishi S; Yamamoto K; Abe H; Nagai K; Doi T
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E418-E431. PubMed ID: 30601699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.
    Tominaga T; Abe H; Ueda O; Goto C; Nakahara K; Murakami T; Matsubara T; Mima A; Nagai K; Araoka T; Kishi S; Fukushima N; Jishage K; Doi T
    J Biol Chem; 2011 Jun; 286(22):20109-16. PubMed ID: 21471216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
    Mima A; Matsubara T; Arai H; Abe H; Nagai K; Kanamori H; Sumi E; Takahashi T; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Sep; 86(9):927-39. PubMed ID: 16767106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
    Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
    Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy.
    Kishi S; Abe H; Akiyama H; Tominaga T; Murakami T; Mima A; Nagai K; Kishi F; Matsuura M; Matsubara T; Iehara N; Ueda O; Fukushima N; Jishage K; Doi T
    J Biol Chem; 2011 Sep; 286(37):32162-9. PubMed ID: 21795715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
    Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
    Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
    Abe H; Matsubara T; Arai H; Doi T
    Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
    Abe H
    Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleraxis modulates bone morphogenetic protein 4 (BMP4)-Smad1 protein-smooth muscle α-actin (SMA) signal transduction in diabetic nephropathy.
    Abe H; Tominaga T; Matsubara T; Abe N; Kishi S; Nagai K; Murakami T; Araoka T; Doi T
    J Biol Chem; 2012 Jun; 287(24):20430-42. PubMed ID: 22474292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
    Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
    Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy.
    Araoka T; Abe H; Tominaga T; Mima A; Matsubara T; Murakami T; Kishi S; Nagai K; Doi T
    Mol Cells; 2010 Sep; 30(3):209-18. PubMed ID: 20803090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.
    Wu P; Wang Y; Davis ME; Zuckerman JE; Chaudhari S; Begg M; Ma R
    J Am Soc Nephrol; 2015 Nov; 26(11):2691-702. PubMed ID: 25788524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca
    Wu P; Ren Y; Ma Y; Wang Y; Jiang H; Chaudhari S; Davis ME; Zuckerman JE; Ma R
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1090-F1100. PubMed ID: 28298362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
    Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
    Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.
    Abe H; Matsubara T; Iehara N; Nagai K; Takahashi T; Arai H; Kita T; Doi T
    J Biol Chem; 2004 Apr; 279(14):14201-6. PubMed ID: 14732718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.